title: Revisiting the frontiers of pharmacogenomics of colon cancer.
authors.affiliation: Geriatrics Unit, Centre Hospitalier Lyon Sud, Pierre-Bénite, France & Lyon University, Lyon, France. claire.falandry@chu-lyon.fr
authors.forename: Claire
authors.initials: C
authors.lastname: Falandry
authors.forename: Marc
authors.initials: M
authors.lastname: Bonnefoy
authors.forename: Gilles
authors.initials: G
authors.lastname: Freyer
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000971:Antineoplastic Combined Chemotherapy Protocols; D054316:Biomarkers, Pharmacological; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D008297:Male; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D011799:Quinazolines / Q000494:pharmacology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D054316:Biomarkers, Pharmacological; D066246:ErbB Receptors; D005472:Fluorouracil; D006877:Hydroxamic Acids; D009944:Organoplatinum Compounds; D017346:Protein Serine-Threonine Kinases; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases